Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Domenico Russo et al.|The Lancet Haematology|2020Cited by 553
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell TransplantationCristina Cunha, Agostinho Carvalho, Franco Aversa et al.|New England Journal of Medicine|2014Cited by 301
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective surveyEnrico Maria Trecarichi, M. Tumbarello, Livio Pagano et al.|Clinical Microbiology and Infection|2014Cited by 241
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendationsLivio Pagano, Marco Sanna, Alessandro Busca et al.|Blood Reviews|2016Cited by 141
Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registriesLivio Pagano, Maria J. G. T. Vehreschild, Oliver A. Cornely et al.|Haematologica|2013Cited by 122